Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has 250 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 12,229,500 | 900,000 | 7.94% | $181,241,190.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 11,329,500 | 0 | 0.00% | $180,705,525.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 7,928,129 | 479,271 | 6.43% | $126,453,658.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 7,845,521 | -82,608 | -1.04% | $116,270,621.00 |
| NEA Management Company, LLC | 31 Mar, 2026 | 3,969,834 | 0 | 0.00% | $63,318,852.00 |
| NEA Management Company, LLC | 31 Mar, 2026 | 3,969,834 | 0 | 0.00% | $58,832,940.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 3,428,705 | 1,465,963 | 74.69% | $50,813,408.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Mar, 2026 | 3,387,194 | 13,173 | 0.39% | $54,025,744.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Mar, 2026 | 3,284,368 | -102,826 | -3.04% | $48,674,334.00 |
| State Street Corp | 31 Mar, 2026 | 2,527,099 | 25,107 | 1.00% | $37,451,607.00 |
| State Street Corp | 31 Mar, 2026 | 2,501,992 | -191,763 | -7.12% | $39,906,772.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,232,548 | 15,633 | 0.71% | $33,086,365.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,216,915 | 270,130 | 13.88% | $35,359,797.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 2,012,666 | 1,170,639 | 139.03% | $32,102,022.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 1,962,742 | 621,675 | 46.36% | $31,305,735.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 1,874,597 | 299,640 | 19.03% | $27,781,530.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 1,663,835 | 73,700 | 4.63% | $24,658,035.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 1,590,135 | 140,535 | 9.69% | $25,362,653.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 1,574,957 | 91,825 | 6.19% | $25,120,564.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 1,572,983 | 40,710 | 2.66% | $23,311,608.00 |